NCT06967506

Brief Summary

Otitis media with effusion (OME) is a common condition in which fluid collects behind the eardrum without signs of infection. It can cause hearing problems and discomfort. Many children get better with medication, but in some cases, the condition becomes long-term and may require surgery. OME is caused by dysfunction of the Eustachian tube, which helps balance the air pressure between the middle ear and the back of the nose (nasopharynx). Restoring proper airflow to the middle ear is important. In addition to medication, physicians often recommend pressure-based exercises such as balloon-blowing, swallowing exercises, the Valsalva maneuver, or chewing gum. These exercises help open the Eustachian tube by creating positive pressure in the nasopharynx, which can improve ear ventilation and reduce symptoms by relieving negative pressure in the middle ear. This study will test the effect of a breathing exercise device called AirOFit PRO™ (AirOFit, Copenhagen, Denmark) in children with OME. Currently, there are no studies in the medical literature showing whether AirOFit PRO™ is effective in treating OME. If this study finds that using the AirOFit PRO™ helps children recover more quickly, it could be an important step in preventing chronic OME and reducing the need for surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2026

Completed
Last Updated

May 5, 2026

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

April 21, 2025

Last Update Submit

May 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Resolution of Tympanic Membrane Appearance and Normalization of Tympanometric Values

    Participants' follow-up will be concluded upon achieving both (1) normalization of tympanic membrane appearance as determined by otoscopic examination (i.e., intact, translucent, and non-retracted membrane without signs of inflammation or effusion), and (2) tympanometric values within normal limits, defined as a Type A tympanogram \[peak pressure between -100 and +50 decapascals (daPa), static acoustic compliance between 0.3 and 1.5 milliliters (mL), and external ear canal volume (ECV) within normal pediatric reference ranges for ages 4-10 years (0.3-1.0 mL)\].

    Participants will be followed weekly for up to 3 months after enrollment, or until resolution criteria are met, whichever occurs first.

Study Arms (2)

The group with OME performing breathing exercises

EXPERIMENTAL

The blowing exercises to be performed with AirOFit PRO will be carried out as follows: 1. Inhalation power will be adjusted: Using the device's own settings, inspiration will be performed with minimal effort for measurement. The participant will be asked to perform 3 maximum efforts at 30-second intervals, and the highest measured value will be recorded. 2. Exhalation power: Using the device's own settings, expiration will be performed with maximum effort for measurement. The participant will be asked to perform 3 maximum efforts at 30-second intervals, and the highest measured value will be recorded. 3. These exercises will be performed at least twice a day, preferably three times (morning/noon/evening).

Device: Blowing exercise group

Control group

NO INTERVENTION

In this group, no blowing exercises will be performed apart from the routine OME treatment.

Interventions

Maximum effort exhalation exercises using the AirOFitPRO will be performed three times daily. Each session will be conducted for a minimum duration of five minutes, with 30-second intervals between each effort.

The group with OME performing breathing exercises

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 4 and 10 years.
  • Presence of documented OME findings in otoscopic examination and audiological measurements.
  • Absence of any ear disease that could affect audiometric or tympanometric findings.
  • Legal guardian consent must be obtained.

You may not qualify if:

  • Presence of active upper respiratory infection symptoms.
  • Presence of a chronic ear disease that could affect study outcomes (e.g., chronic otitis, tympanosclerosis, etc.).
  • Presence of diseases affecting respiratory system functions (e.g., pneumonia, pleurisy, empyema, pneumothorax, hemothorax, hydrothorax, atelectasis, pulmonary edema, pulmonary hypertension, emphysema).
  • Inability to perform respiratory exercises due to a general condition disturbance.
  • Presence of psychomotor retardation that prevents the participant from performing blowing exercises.
  • Refusal of the patient or their guardian to participate in the study without providing a reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uşak University Faculty of Medicine

Uşak, Merkez, 64100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Otitis Media with Effusion

Condition Hierarchy (Ancestors)

Otitis MediaOtitisEar DiseasesOtorhinolaryngologic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2025

First Posted

May 13, 2025

Study Start

September 25, 2024

Primary Completion

December 12, 2025

Study Completion

January 25, 2026

Last Updated

May 5, 2026

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Sharing personal data must comply with the data protection principles in Turkey.

Locations